<DOC>
	<DOCNO>NCT01853059</DOCNO>
	<brief_summary>Anal cancer treat chemoradiotherapy- combined chemotherapy radiotherapy . This successful ( 75 % long term survival ) . During course radiotherapy , organ pelvis may damage . This lead long-term problem possible change skin , bowel diarrhoea incontinence problem , bladder shrinkage incontinence urine , sexual problem include impotence ejaculatory problem , pain sexual intercourse vaginal dryness shrinkage . Patients offer help side effect . At present , little information effect treatment patient 's quality life , make difficult judge new treatment method well . This project measure quality life patient 's perspective treatment anal cancer . It also gather preliminary data quality life introduction new technique precise 3D-targeting radiotherapy beam cancer , call IMRT .</brief_summary>
	<brief_title>Functional Outcomes Following Anal Cancer Treatment</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms , Squamous Cell</mesh_term>
	<mesh_term>Anus Neoplasms</mesh_term>
	<criteria>Participant willing able give inform consent participation study . Male Female , age 18 year . Squamous cell basaloid carcinoma anal canal adenocarcinoma , melanoma , lymphoma , sarcoma malignancy anal canal Any synchronous metanchronous pelvic malignancy nonanal origin ( eg . prostatic , genital tract ) unable complete questionnaire</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Anal cancer</keyword>
	<keyword>Squamous cell cancer</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Chemoradiotherapy</keyword>
	<keyword>Conformational radiotherapy</keyword>
	<keyword>Intensity modulate radiation therapy</keyword>
	<keyword>IMRT</keyword>
</DOC>